Last reviewed · How we verify
Desvenlafaxine succinate 100mg — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Desvenlafaxine succinate 100mg (Desvenlafaxine succinate 100mg) — Seoul National University Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Desvenlafaxine succinate 100mg TARGET | Desvenlafaxine succinate 100mg | Seoul National University Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Desvenlafaxine succinate 100mg CI watch — RSS
- Desvenlafaxine succinate 100mg CI watch — Atom
- Desvenlafaxine succinate 100mg CI watch — JSON
- Desvenlafaxine succinate 100mg alone — RSS
Cite this brief
Drug Landscape (2026). Desvenlafaxine succinate 100mg — Competitive Intelligence Brief. https://druglandscape.com/ci/desvenlafaxine-succinate-100mg. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab